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The Na+/H+ exchanger regulatory factor (NHERF) is a
key adaptor protein involved in the anchoring of ion
channels and receptors to the actin cytoskeleton
through binding to ERM (ezrin/radixin/moesin) pro-
teins. NHERF binds the FERM domain of ERM pro-
teins, although NHERF has no signature Motif-1
sequence for FERM binding found in adhesion mole-
cules. The crystal structures of the radixin FERM
domain complexed with the NHERF-1 and NHERF-2
C-terminal peptides revealed a peptide binding site
of the FERM domain specific for the 13 residue motif
MDWxxxxx(L/I)Fxx(L/F) (Motif-2), which is distinct
fromMotif-1. ThisMotif-2 forms an amphipathic a helix
for hydrophobic docking to subdomain C of the FERM
domain. This docking causes induced-fit conforma-
tional changes in subdomain C and affects binding
to adhesion molecule peptides, while the two binding
sites are not overlapped. Our studies provide struc-
tural paradigms for versatile ERM linkages between
membrane proteins and the cytoskeleton.
Introduction
NHERF is the best-studied adaptor protein that is highly
expressed in epithelial cells and localized at the apical
plasma membrane. NHERF contains two PSD-95/Dlg/
ZO-1 (PDZ) homology domains that directly bind target
proteins. The growing list of potential NHERF targets in-
cludes nine ion channels/transporters such as Na+/H+
exchanger 3 (NHE3) (Weinman et al., 1995) and the cys-
tic fibrosis transmembrane conductance regulator
(CFTR) (Wang et al., 1998), seven G protein-coupled re-
ceptors (GPCRs) containing the b2 adrenergic receptor
(b2AR) (Hall et al., 1998) and the parathyroid hormone 1
receptor (PTH1R) (Mahon et al., 2002), in addition to cy-
toplasmic signaling, scaffold, and nuclear proteins (re-
viewed in [Shenolikar et al., 2004]). Platelet-derived
growth factor receptor (PDGFR) (Maudsley et al., 2000)
*Correspondence: hakosima@bs.naist.jpand epidermal growth factor receptor (EGFR) (Lazar
et al., 2004) are also NHERF targets. Molecular and cel-
lular studies over the past decade have demonstrated
that NHERF is a key regulator for the targeting of these
proteins and for controlling their activity.
Two NHERF isoforms (NHERF-1 and NHERF-2) show
55% sequence identity and have also been referred to
as ERM binding phosphoprotein 50 (EBP50) and Na+/H+
exchanger 3 kinase A regulatory factor (E3KARP), re-
spectively (Reczek et al., 1997; Yun et al., 1997). NHERFs
bind ERM proteins, which mediate the association of ac-
tin filaments with plasma membranes by binding to both
membrane-associated adhesion molecules and actin fil-
aments. ERM proteins are involved in cell adhesion, mo-
tility, and morphogenesis, and they participate in signal
transduction pathways (for reviews see [Tsukita and Yo-
nemura, 1999; Sun et al., 2002]). Recently, ERM proteins
and their closely related homolog merlin, the gene prod-
uct of neurofibromatosis type 2 (NF2) tumor suppressor,
were shown to play a role in cancer development
(McClatchey, 2003). ERM proteins have not been re-
ported to bind directly to ion channels/receptors that
bind NHERFs. NHERFs act as a link between the ion
channels/receptors and ERM proteins, and the NHERF-
ERM-mediated anchoring to the actin cytoskeleton stim-
ulates the activity of these membrane proteins.
ERM proteins are present in the cytosol in an inactive
form, in which both the adhesion molecule binding site
on the N-terminal FERM (4.1 and ERM) domain and the
actin filament binding site on the C-terminal tail (C-tail)
domain are masked (Gary and Bretscher, 1995). This in-
active form is activated after binding to phosphatidyli-
nositol 4,5-bisphosphate (PIP2) (Hirao et al., 1996) and
phosphorylation at the C-tail domain (Matsui et al.,
1999). Both events are associated with the downstream
Rho signaling pathway. Recent cell biological studies
demonstrated that PIP2 binding is the primary require-
ment in the activation of ERM proteins (Yonemura
et al., 2002; Fievet et al., 2004). Crystallographic studies
have shown structures of the moesin masked form
(Pearson et al., 2000) and the radixin unmasked form
bound to the inositol-1,3,5-trisphosphate (IP3, the polar
head group of PIP2) (Hamada et al., 2000).
The FERM domains of ERM proteins and merlin con-
sist of ca. 300 residues containing three subdomains,
A, B and C, and they bind a variety of target proteins.
The major targets are adhesion molecules such as
ICAM-2. A recent crystal structure of the radixin FERM
domain complexed with the ICAM-2 cytoplasmic tail re-
vealed that the FERM domain recognizes the signature
sequence RxxTYxVxxA (Hamada et al., 2003). This and
the homologous sequence motif, (R/K/Q)xxT(Y/L)xx(A/G)
(Motif-1), are found in juxtamembrane regions of the cy-
toplasmic tails of ERM-interactive adhesion molecules
including CD44, CD43, ICAM-1, ICAM-3, L1-CAM,
VCAM-1, PSGL-1, syntenins, and syndecans. Interest-
ingly, the C-terminal region of NHERFs binds ERM pro-
teins, even though this region contains no signature se-
quence homologous to Motif-1 (Yun et al., 1998;
Reczek and Bretscher, 1998). Here, we report on the
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peptides and show a new, to our knowledge, peptide
binding site for NHERF peptides that have a novel signa-
ture sequence, MDWxxxxx(L/I)Fxx(L/F) (Motif-2). The
Motif-2 amino acid sequence forms an amphipathicahe-
lix for hydrophobic docking to the groove formed by two
b sheets from the b sandwich of subdomain C. This bind-
ing site is distinct from the Motif-1 binding site at the
groove formed by strand b5C and helix a1C. Thus, the
FERM domain provides two distinct binding sites for
two classes of target proteins with different specificity.
We also provide in vitro evidence for the interference
concerning the binding of NHERF and adhesion mole-
cules such as ICAM-2 to the FERM domain.
Results
Structure Determination and Overall Structure
Crystals of the radixin FERM domain bound to each
NHERF peptide were obtained by using NHERF-1 and -2
peptides consisting of the 28 C-terminal residues
(331KERAHQKRSS KRAPQMDWSKKNELFSNL358 and
310KEKARAMRVNKRAPQMDWNRKREIFSNF337), re-
spectively (Terawaki et al., 2003). Our binding assay
showed that the peptides bind the FERM domain with
high affinity and a dissociation constant, Kd, in the nano-
molar range (described below). Other peptides (residues
311–338 of NHERF-1 and residues 291–318 of NHERF-2)
that lack the extreme C-terminal 20 residues exhibited no
binding to the FERM domain (data not shown). These re-
sults are consistent with the previous report that showed
that the FERM binding region is located within the C-ter-
minal 23 residues of NHERF-2 (Yun et al., 1998). Similarly,
the C-terminal 30 residue peptide of NHERF-1 was
shown to be sufficient for binding to the ezrin FERM do-
main (Reczek and Bretscher, 1998). Both crystals con-
tain four molecular complexes per asymmetric unit.
The structure was determined by molecular replacement
by using the free radixin FERM domain (Hamada et al.,
2000). The FERM-NHERF-1 and FERM-NHERF-2 com-
plexes were refined to 2.5 A˚ and 2.8 A˚ resolution, respec-
tively (see Table S1 in the Supplemental Data available
with this article online). The structure of four crystallo-
graphic-independent complexes was essentially the
same in both crystals. Moreover, no significant overall
structural deviation was found in the FERM domains of
the two complexes; the averaged root-mean-square de-
viation (rmsd) in Ca-carbon atoms was 0.35 A˚. Our dis-
cussion will therefore focus on the structure of the
FERM-NHERF-1 complex followed by reference to a lo-
cal structural change in the NHERF-2 peptide.
As previously reported (Hamada et al., 2000, 2003), the
FERM domain consists of three subdomains, A, B, and
C. Subdomain C, which folds into a standard seven-
stranded b sandwich (strands b1C–b7C) with one long
capping a helix (a1C), resembles phosphotyrosine bind-
ing (PTB) domains. Subdomain A has a typical ubiquitin
fold, while subdomain B has an a helix bundle structure.
Both the NHERF-1 and NHERF-2 peptides are located at
the molecular surface formed by subdomains C and B
(Figure 1A). Compared with the free FERM domain (Ham-
ada et al., 2000), the overall rmsds of the NHERF bound
FERM domains are relatively large (0.96 A˚). The devia-
tions obtained from the pairwise superposition of eachsubdomain showed that the major deviation is associ-
ated with subdomain C (1.08 A˚), which binds the NHERF
peptide, while the deviations pertaining to subdomains A
and B are relatively small (0.46 A˚ and 0.68 A˚, respectively)
(Figure 1B). The mechanism concerning the structural
changes in subdomain C will be discussed later.
NHERF Peptide Conformations
The NHERF peptides consist of two regions (Figure 1C).
The N-terminal region (residues 331–345 for NHERF-1)
includes basic residues, while the C-terminal region
(346–358) contains nonpolar residues. In the current
map, no model of the peptide was built for the 8 (for
NHERF-1) and 10 or 11 (for NHERF-2) N-terminal resi-
dues, which were poorly defined. The structured regions
of the NHERF-1 peptide (blue in Figure 1A) form a N-ter-
minal loop (residues 339–347) that is followed by a 3-turn
amphipathic a helix consisting of the extreme C-terminal
11 residues (348–358). At the helix surfaces, two aro-
matic side chains from Trp348 and Phe355 protrude
from one side (Figure 1D). The aliphatic part of the
Lys351 side chain makes contact with the aromatic
ring of Trp348. On another side of the helix, three ali-
phatic side chains (from Met346, Leu354, and Leu358)
interact side by side. These aromatic and aliphatic resi-
dues form hydrophobic molecular surfaces on the helix.
The other side of the helix is occupied by polar residues,
including poorly defined Lys350 and Glu353, which pro-
trude toward the solvent region. The helix is stabilized
by the side chain of Asp347, which forms the N-terminal
cap of the a helix by hydrogen bonding to the main chain
amide group(s) of Ser349 and/or Lys350. The helices of
the NHERF-1 peptides in four crystallographic-indepen-
dent complexes are well overlaid and have a small aver-
aged rmsd (0.29 A˚). In contrast to the rigidity of the heli-
ces, most of the residues in the N-terminal loop region
seem to be flexible in our complexes. In fact, the struc-
ture of the N-terminal loop regions of the four indepen-
dent NHERF peptides displayed different conformations
(Figure 2A, left).
Peptide Recognition
The interface between the NHERF-1 peptide and the
FERM domain buries 1,630 A˚2 of the total accessible
surface area, including both the peptide and the domain.
The C-terminal helix of the peptide docks to the groove
between two b sheets, the four-stranded sheet b1C-
b2C-b3C-b4C (sheet b1C–b4C) and the three-stranded
sheet b5C-b6C-b7C (sheet b5C–b7C), from the b sand-
wich of subdomain C (Figures 1A and 1B). The contacts
are predominantly mediated by nonpolar interactions in-
volving side chains (Figures 2B and 2C). The groove pro-
vides two hydrophobic pockets for accommodation of
Trp348 and Phe355 from the NHERF-1 peptide (Fig-
ure 2A, right). These 2 residues are completely buried
at the interface. The two pockets are separated by 2 res-
idues, Phe240 from sheet b1C–b4C and Phe267 from
sheet b5C–b7C. The pocket for Trp348 is formed by
strands b4C (Phe240) and b6C (Ile257 and Pro259) and
by loop b6C–b7C (Pro265). The pocket for Phe355 is
formed by strands b7C (Phe267 and Phe269), b2C
(Leu216), and b3C (Ile227) and by the aliphatic part of
the Lys211 side chain from loop b1C–b2C. Thus,
both pockets are formed by residues from both the
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(A) Ribbon representations of the radixin FERM domain bound to the NHERF-1 (blue) and NHERF-2 (light blue) peptide. The radixin FERM domain
consists of subdomains A (the N-terminal 82 residues in green), B (residues 96–195 in red), and C (residues 204–297 in yellow).
(B) A stereoview of the NHERF bound radixin FERM domain (the same color codes as in [A]) superimposed on the free form (gray).
(C) Peptides synthesized based on the sequence of the NHERF-1 and -2 tails were used for the structural work. The 20 residues (339–358) of the
28 residue NHERF-1 peptide defined on the current map display a N-terminal loop followed by an a helix consisting of the C-terminal 11 residues.
Key residues involved in binding to the radixin FERM domain are highlighted in yellow (see text). Conserved residues between NHERF peptides
and the C-terminal tail of ERM proteins are underlined.
(D) A helical projection of the C-terminal helix of the NHERF-1 peptide found in the FERM-NHERF-1 complex crystal. The side chains are shown as
stick models inyellow (nonpolar residues)and cyan (polar residues).The poorly definedside chains of K350and E353 (smaller red labels)areomitted.b1C–b4C and b5C–b7C sheets (Figure 3). In addition to
the aromatic residues, Met346, Leu354, and Leu358
from the NHERF-1 peptide align their side chains to-
gether toward the hydrophobic groove of subdomain
C and associate with nonpolar residues (Ile238, Ile227,
and Leu216) from sheet b1C–b4C.
In contrast to the wealth of nonpolar intermolecular
interactions, only six hydrogen bonds were found be-
tween the NHERF-1 peptide and subdomain C. These in-
teractions involve side chains from 3 NHERF-1 residues
(Trp348, Lys351, and Asn352) and from 3 radixin resi-
dues (Asn210, Thr214, and Glu244), as well as main
chains (Figure 2C). The terminal carboxylate group of theC-terminal end residue (Leu358 of NHERF-1) forms bifur-
cated hydrogen bonds with the side chains of Asn210
and Thr214 from the FERM domain. The side chain of
Asn210 also forms a hydrogen bond with the main chain
of NHERF-1 Phe355. The N-terminal loop of the NHERF-1
peptide protrudes toward the molecular surface be-
tween subdomains B and C (Figure 1A). Interestingly,
this molecular surface contains many acidic residues
(Figure 2A), suggesting the presence of electrostatic in-
teractions between the positively charged N-terminal
basic residues of the peptide and the negatively charged
residues located at the acidic groove formed by subdo-
mains B and C.
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(A) Front (left) and side (right) views of surface electrostatic potentials of the radixin FERM domain. The front view is viewed from the same di-
rection as in Figure 1A. Positive (blue, +14 kT/e) and negative (red, 214 kT/e) potentials are mapped on the van der Waals surfaces. The four
crystallographic-independent NHERF-1 peptides are shown in tube models (cyan). A side view of the FERM domain is shown without the
NHERF-1 peptide to show two hydrophobic pockets for the Trp348 and Phe355 side chains from the NHERF peptide.
(B) A close-up view of the amphipathic helix of the NHERF-1 peptide (cyan) docked to the groove formed by the b sandwich of subdomain C
(yellow). Hydrogen bonds are shown with dotted lines. The C-terminal carboxyl group of Leu358 is labeled with CPX.
(C) Schematic diagram of the interaction between the NHERF-1 peptide (residues 339–358, cyan main chain bonds) and the FERM domain
(brown main chain bonds) with atom colors: black, C; blue, N; red, O; yellow, S. Polar contacts are shown with red, dashed lines, and hydrophobic
contacts are indicated by arcs with radiating spokes. A list of all residues involved in binding either peptide together with their distances is given
in Table S2.
(D) A close-up view of the superimposed C-terminal region of NHERF-1 (blue) and NHERF-2 (yellow) peptides bound to the FERM domains.
Leu354 and the C-terminal end residue of NHERF-1, Leu358, are replaced with Ile333 and Phe337 in NHERF-2, respectively. These residues in-
teract with residues from the FERM domains drawn in cyan (NHERF-1 bound form) and gray (NHERF-2 bound form).In the FERM-NHERF-2 complex, the peptide-protein
interactions are similar to those described above, while
Ile333 and Phe337 of NHERF-2 replace Leu354 and
Leu358 of NHERF-1. These replacements induce local
conformational changes in the C-terminal part of the
NHERF helix (Figure 2D), resulting in modified side chain
packing of 2 residues against the groove of subdomain
C. This double replacement would enable a closer sidechain packing of Phe/Ile in NHERF-2 compared to that
of Leu/Leu in NHERF-1.
Determinant NHERF Residues for FERM Binding
Based on our crystal structures, the binding affinity for
several mutated NHERF-1 peptides was examined by
using surface plasmon resonance (SPR) measurements
to identify determinant residues for the specificity
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781Figure 3. Sequence Alignments of Subdomain C from Related FERM Domains
The FERM subdomain C of mouse radixin, ezrin, and moesin; human band 4.1 (hP 4.1); and talin (hTalin) are aligned with the secondary structure
elements of the radixin FERM subdomain C at the top: a helix (a green rectangle) and b strands (red arrows). Boxed residues participate in
nonpolar (highlighted in yellow) and polar (blue for side chain and white for main chain) interactions with the NHERF-1 peptide. Mouse FERM
domains exhibit 100% sequence identity with those of human.(Table 1). The wild-type peptide binds the radixin FERM
domain with extremely high affinity (Kd of 1.7 nM). We
identified 3 nonpolar residues, Met346, Trp348, and
Phe355, as the determinant residues (NHERF-1/M346,
NHERF-1/W348, and NHERF-1/F355 in Table 1, respec-
tively). The most important residue is Trp348, which
makes both nonpolar and hydrogen bonding interac-
tions, as described above. Each mutation of these 3 res-
idues reduces the binding affinity by from 25- to 33-fold,
which corresponds to a loss in binding free energy of 8–9
kJ/mol. Compared with completely buried Trp348 and
Phe355, Met346 is relatively exposed to solvent, while
the contribution to the binding affinity is comparable to
the 2 buried residues. This could be due to its role in sta-
bilizing the N-terminal part of the NHERF helix. The next
determinant residue was found to be C-terminal Leu358,
the mutation of which resulted in 7-fold weaker binding.
Leu354 at the molecular surface showed a relatively
small contribution to the binding affinity. This may be
because alanine replacement alone is not enough to
completely abolish the Leu side chain contribution to
the binding.
The contribution of 2 polar residues, Lys351 and
Asn352, was found to be even smaller; each mutation
caused only a 2-fold reduction in the binding affinity.
Contrary to this small contribution, the N-terminal basic
region, which may be flexible but seems to interact with
the acidic groove of the FERM domain (Figure 2A, left),
was found to be important for strong binding of NHERF.
Truncation of the N-terminal basic region resulted in
a significant decrease in the binding affinity (NHERF-1/
C-term in Table 1). We failed to detect significant binding
of the 13 residue N-terminal basic region of the NHERF-1
peptide in our SPR measurements (NHERF-1/N-term).
This suggested dynamic properties of the ionic interac-
tion between the N-terminal basic region and the FERM
acidic groove. These observations are reminiscent of
the flexible basic region of the ICAM-2 cytoplasmic
tail, which aligned with the acidic groove of the FERM
domain in the FERM-ICAM-2 complex and contributes
to the strong binding (Hamada et al., 2003).
The bifurcated hydrogen bonds formed by the C-ter-
minal residue Leu358 are mediated by one oxygen
atom of the terminal carboxylate group (Figures 2Band 2C). The issue concerning whether the terminal car-
boxylate group is essential for peptide binding was ex-
amined by using a peptide with 3 additional Ala residues
at the C terminus (NHERF-1/C-AAA in Table 1). This
replaces the negatively charged carboxyl group with a
peptide bond group to an Ala residue. It was found
that the replacement reduced the binding affinity by
7-fold. The magnitude of this reduction was unexpect-
edly small. The modified peptide still exhibited high af-
finity for the FERM domain and had a Kd value of 12 nM.
The binding affinity for mutated NHERF-2 peptides
was also examined (Table 2). We found that the contri-
bution of 2 nonconserved residues, Ile333 and Phe337,
of NHERF-2 to the FERM binding is similar to that of
the corresponding residues of NHERF-1. Moreover,
truncation of the N-terminal basic region resulted in
a significant decrease in the binding affinity (NHERF-2/
C-term in Table 2). These results are consistent with
the structural similarities between the FERM-NHERF-1
and FERM-NHERF-2 complexes.
We propose Motif-2, a novel, to our knowledge, 13 res-
idue motif with MDWxxxxx(L/I)Fxx(L/F), as the signature
sequence recognized by the FERM domain. The key ele-
ments in this new, to our knowledge, motif are M, W, and
F, which play a central role in nonpolar interactions with
the FERM domain. The D residue is not involved in the in-
termolecular interaction, but it represents the N-terminal
cap important for stabilizing the a helix of the motif.
The C-terminal L residue, which is replaced with F in
NHERF-2, represents the next determinant residue. The
other L residue, which is replaced with I in NHERF-2, has
some significance in the binding. Finally, the N-terminal
flanking basic region is essential for the strong binding.
The unexpectedly small contribution of the carboxyl
group of the C-terminal end residue implies that the
FERM domain could bind Motif-2, located at loop re-
gions of proteins other than the C-terminal regions.
Masking/Unmasking the Motif-2 Binding Site
and Membrane Association
The FERM domain of ERM proteins has been found to
display multiple binding modes for target molecules
(Figures 4A–4D). We noticed that the binding mode of
the NHERF peptide helix is comparable to that of helix
Structure
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(Figure 4D). A superposition of the C-tail domain onto
the FERM domain bound to the NHERF-1 peptide indi-
cated significant overlap between these helices with
a relatively small rmsd (0.51 A˚) (Figure 4E). This overlap
of the binding regions clearly demonstrated the counter-
action of the C-tail domain with the NHERF peptides for
FERM binding. A similar overlap was also suggested by
a preliminary study with a longer NHERF peptide (Finn-
erty et al., 2004). A structure-based comparison of the
sequences, however, showed limited homology of the
helices (Figure 1C). In our SPR measurements, a 15 res-
idue peptide encompassing the helix D residues ex-
hibited no detectable binding to the FERM domain (Rad-
ixin/C-term in Table 1). A longer peptide (28 residues;
Radixin/556–583 in Table 1) of the C-tail domain still ex-
hibited weak binding to the FERM domain; binding was
42-fold weaker than that for the same length NHERF-1
peptide. Our results suggested that binding of helix D
to the FERM domain requires other parts of the C-tail
domain for masking of the FERM domain. The C-tail do-main replaces 2 key residues, Met346 and Trp348, of
NHERF with glycine and threonine, respectively (Fig-
ure 4F); this replacement results in a loosening of exten-
sive hydrophobic interactions. Alternatively, the C-tail
domain replaces Asn352 of NHERF with an isoleucine
residue, making hydrophobic contacts with the FERM
domain. Ser356 of NHERF is replaced with glutamate,
which forms an additional hydrogen bond with the FERM
domain. These alternative interactions enable both the
helices displaying poor sequence homology to bind
the same groove of subdomain C. Other interactions
are basically common in the two helices, and a compar-
ison of all interactions is summarized in Figure S1.
Subdomains A and C of the FERM domain form the
highly positively charged surface with a cleft for IP3
binding (Figure 4A). This flat surface was proposed to
associate plasma membrane (Hamada et al., 2000)
(Figure 5A). The PIP2 binding site is accessible even
in the inactive, closed form of ERM proteins, whereas
the phosphorylation site is located at the interface inac-
cessible to protein kinase(s) without structural changes.
Structure of the FERM-NHERF Domain
783Table 2. Binding Affinities of the NHERF-2 Peptides for the Radixin FERM DomainPIP2 binding would open the structure, thus exposing
both actin and adhesion molecule binding sites, as
well as the site for phosphorylation, which subsequently
stabilizes the open form. The proposed orientation of
the FERM domain associated with the membrane also
enables subdomains C and B to interact with the cyto-
plasmic tails of adhesion molecules (Hamada et al.,
2003). Similarly, in the proposed orientation, the NHERF
binding site at subdomains C and B is accessible to the
NHERF tail. PIP2-mediated activation restricts ERM
opening to the membrane. Adhesion molecules can
then lock the ERMs at adhesion sites. The adhesion mol-
ecules, which contain positively charged regions just in-
side the cytoplasmic side of the membrane, may also re-
cruit ERMs by pooling PIP2.
The PIP2 binding site of the FERM domain has no
overlap with either the NHERF or ICAM-2 binding site.
Our SPR measurements showed that di-butanoyl-PIP2
has no significant effect on the peptide bindings of the
FERM domain even at an extremely high (50–100 mM)
concentration of this soluble PIP2 (Figure 5B). Using
PIP2-containing lipid, PIP2/POPC (1:9), vesicles, PIP2
binding to the FERM domain was found to have a Kd
value in the micromolar range (3.02 mM), which is much
weaker than the peptide bindings (Figure 5C). Similar af-
finity was also observed for PIP2/POPC (3:7) vesicles.
These results suggest that PIP2 binding does not inter-
fere with the peptide bindings and that the PIP2 bound
FERM domain could bind these target proteins.
Structural Changes from the Free and the ICAM-2
Bound Forms
The binding site for the NHERF peptides does not over-
lap with the ICAM-2 binding site (Figures 4B and 4C).
Nevertheless, the presence of two closely positioned
peptide binding sites displaying different target speci-
ficities implies that ERM targets from two different
classes may compete for binding to endogenous ERM
proteins and thereby modulate each other’s function,
which requires that they bind to ERM proteins. Com-pared with the free form of the FERM domain, local but
significant structural changes (the rmsd of 1.08 A˚) were
found in subdomain C of the current NHERF bound
FERM domain (Figures 6A and 6B). In comparison with
the ICAM-2 bound FERM domain, we found larger struc-
tural changes (1.32 A˚), which are induced by NHERF-1
binding to enlarge the b sandwich groove (ca. 2 A˚) with
displacement of sheet b5C–b7C (Figure 6C). Interest-
ingly, this displacement resulted in a narrowing of the
groove between strand b5C and helix a1C, the major
site for ICAM-2 binding (Hamada et al., 2003) (Figure 6C
and Figure S2). This indicated that structural changes
induced by NHERF binding might interfere with Motif-1
binding.
The induced-fit structural changes involve rearrange-
ment of the side chain packing of the b sandwich and
many small conformational changes of other residues
in subdomain C. These changes seem to be initiated
by the insertion of 2 hydrophobic residues, Phe355
and Trp348 of NHERF, into the hydrophobic pockets of
subdomain C. The side chain phenyl group of Phe355
enlarges the pocket by pushing Phe267 and Phe269 of
subdomain C (Figure 6D). These displacements induce
rotations of the side chains of Phe255 and Phe250.
Simultaneously, Trp348 of NHERF pushes strands b6C
and b7C by contacting two prolines, Pro259 and
Pro265, of subdomain C, inducing rotation of the side
chains of Leu225 and Ile248. These rearrangements of
the side chain packing permit sheet b5C–b7C to slide to-
ward helix a1C without significant perturbation in the b-b
interactions within the sheet (Figures 6E and 6F). Dock-
ing of Trp348 of NHERF into the pocket also induces
a conformational change in loop b6C–b7C and a flip of
the main chain of Asp261 by loosening the hydrogen
bond with the main chain of Ala264.
Interference between Motif-1 and Motif-2 Binding
Using the sensor chips, onto which cytoplasmic pep-
tides of ICAM-2, ICAM-1, V-CAM-1, and CD44 were
immobilized, SPR measurements were performed by
Structure
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(A) The radixin FERM domain (gray) complexed with IP3 (Hamada et al., 2000), which is shown as a ball-and-stick model. Italic labels indicate
subdomains A, B, and C.
(B) The radixin FERM domain complexed with the ICAM-2 cytoplasmic peptide (magenta) (Hamada et al., 2003).
(C) The radixin FERM domain complexed with the NHERF-1 peptide (blue; this work).
(D) The moesin FERM domain complexed the C-tail domain (dark brown) (Pearson et al., 2000).
(E) The C-tail domain (brown) is superimposed with the NHERF-1 peptide (blue) bound to the radixin FERM domain (gray).
(F) Comparison of the C-terminal helix of the NHERF-1 peptide (light blue) bound to the radixin FERM domain and helix D of the moesin C-tail
domain (brown).injecting the purified radixin FERM domain with or with-
out NHERF-1 peptide at different concentrations. It was
found that NHERF-1 peptide reduced the amount of the
FERM domain bound to the ICAM-2 peptide in a concen-
tration-dependent manner (Figure 7A). Previously, the
C-terminal basic region of the ICAM-2 peptide has
been shown to contribute to FERM binding by interact-
ing with the acidic groove between subdomains B and C
(Hamada et al., 2003). Since the N-terminal flexible basic
region of the NHERF-1 peptide also interacts with the
same acidic groove, we speculated that the NHERF-1
peptide might directly compete with the ICAM-2 pep-
tide for binding to the acidic groove. However, the
N-terminal-truncated NHERF-1 peptide was found to
interfere with FERM-ICAM-2 binding (Figure 7B). Based
on these binding experiments, we concluded that the
binding of NHERF and ICAM-2 to the FERM domain is
affected predominantly by induced-fit conformational
changes in subdomain C. Similar results were obtained
for the ICAM-1, V-CAM-1, and CD44 peptides that con-
tain the Motif-1 sequences (Figure 7C). Since the affinity
of the FERM domain to these cytoplasmic peptides are
weaker than that for ICAM-2 (Hamada et al., 2003), the
inhibitory effects of the NHERF-1 peptide on binding of
these peptides are much larger (with a Ki value of ca.
50 nM). Therefore, we believe that NHERF-1 coulddisplace most ERM binding adhesion molecules from
ERM proteins.
Discussion
Examination of our crystal structures revealed a new, to
our knowledge, peptide binding mode to the radixin
FERM domain and provided several implications con-
cerning the physiological role of NHERFs and ERM pro-
teins. We identified determinant residues involved in
NHERF peptide recognition by the radixin FERM domain
and proposed the 13 residue Motif-2, distinct from Mo-
tif-1, for adhesion molecule recognition. Nonpolar inter-
actions are dominant in the FERM-NHERF interaction,
which is consistent with previous observations that
FERM-NHERF binding is highly resistant to high-con-
centration (1–2 M) salt washes (Nguyen et al., 2001).
Key residues in direct interactions with the NHERF pep-
tides are conserved in all members of ERM proteins (Fig-
ure 3), indicating that NHERF binding to other members
of ERM proteins would be essentially the same as those
in our complexes. Moreover, most of these residues are
also conserved in the merlin FERM domain, although
nonhomologous replacement of radixin Pro265 is found
in loop b6C–b7C of merlin subdomain C. These merlin
sequences may modify the pocket for the important
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785Figure 5. Schematic Representation of Membrane Targeting, Unmasking, and Motif-1/Motif-2 Bindings of ERM Proteins and Effects of PIP2
Binding on Peptide Bindings of the FERM Domain
(A) ERM proteins have the N-terminal FERM (a blue triangle) and the C-tail domains (a red block). PIP2 molecules in plasma membranes recruit
ERM proteins in the closed form from the cytosol to the membranes. PIP2 molecules would be colocalized with adhesion molecules that have
a positively charged juxtamembrane region in their cytoplasmic tails. Binding to the negatively charged IP3 head (a yellow hexagon) unmasks
ERM proteins for subsequent binding to the protein targets. The FERM domain of membrane-recruited ERM proteins binds either Motif-1 in the
cytoplasmic tail of adhesion molecules or Motif-2 of NHERF (green with two ovals as two PDZ domains) bound to the cytoplasmic tail of ion chan-
nels, GPCRs, or other receptors, while the C-tail domain binds actin filaments. No simultaneous binding to either Motif-1 of Motif-2 occurs.
(B) Sensor diagrams obtained from SPR measurements with the NHERF-1 (left) or ICAM-2 (right) peptide immobilized to the sensor chip. Purified
radixin FERM domain (100 nM) was injected into the sensor chips with or without soluble di-butanoyl-PIP2, of which concentrations are indicated
(0–100 mM). The NHERF-1 and ICAM-2 peptides are the same as those used in the structural works.
(C) Binding isotherm for the radixin FERM domain and POPC/PIP2 (9:1) vesicles from equilibrium SPR measurements. The Kd value (3.02 6
1.11 mM) was obtained from the theoretical fitted curve (a solid line).tryptophan residue (Trp348 in NHERF-1) and would re-
duce the binding affinity to NHERFs (Reczek and
Bretscher, 1998). The key residues for NHERF binding
are poorly conserved in the FERM domains of talin or
the canonical PTB domains in other signaling proteins.
As the number of known ERM target proteins that bind
the FERM domain increases, so too will our understand-
ing of the potential roles of competition between the tar-
gets or, otherwise, the cooperative binding of multiple
targets. Target proteins that occupy different binding
sites on the FERM domain, and physiological signals
that modify the FERM domain affinity for certain targets,
thereby redirecting its function, needs to be explored.
Using highly purified protein and peptides, results of
experiments presented here clearly revealed that the
Motif-1 and Motif-2 peptides compete for the radixin
FERM domain. It is unlikely that the FERM domain can
bridge two different membrane protein targets to coor-
dinate their cellular function. The proposed competition
between NHERF and adhesion molecules for ERM pro-
teins is reminiscent of direct competition between
b2AR and NHE3 for NHERF, which resolved a long-
standing paradox whereby some cAMP-elevating hor-mones inhibited NHE3 activity, while others like b2AR
increased the activity (Hall et al., 1998).
NHERFs are apical PDZ proteins highly expressed in
epithelial cells and potential regulators of the apical tar-
geting or trafficking of ion transporters and other mem-
brane proteins (Shenolikar et al., 2004). Consistent with
the predominant localization of NHERFs at the apical
cell surface, the growing list of potential NHERF targets
shows a preponderance of membrane proteins such as
ion transporters and receptors, specifically GPCRs.
NHERF-1 has been shown to organize ERM proteins at
the apical membrane of polarized epithelia to maintain
the brush border structures (Morales et al., 2004). More-
over, NHERF-2 and its target, podocalyxin/gp135, par-
ticipate in the formation of a preapical domain during
polarization of MDCK cells (Meder et al., 2005). These
data indicate that functions of NHERF-ERM-F-actin
scaffolding are expanding to include roles in cell polari-
zation induction.
PDZ domain-mediated dimerization of NHERFs
(Fouassier et al., 2000; Shenolikar et al., 2001; Lau and
Hall, 2001) has been shown to facilitate activation of re-
ceptors including PDGFR (Maudsley et al., 2000) and
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786Figure 6. Induced-Fit Structural Changes in Subdomain C Cause Interference between Motif-1 and Motif-2 Binding to the FERM Domain
(A) Side view of superposition of subdomain C in the free and NHERF-1 bound forms. The NHERF-1 peptide (blue) is shown as a stick model.
Loops are colored in green (NHERF-1 bound form) and red (free form). Two structures are superimposed by using helix a1C and sheets b1C–
b4C. These secondary structures display minimum deviations of the mutual positions.
(B) Front view of superposition of subdomain C in the free and NHERF-1 bound forms in (A).
(C) Front view of superposition of subdomain C in the NHERF-1- and ICAM-2 bound forms. The NHERF-1 (blue) and ICAM-2 (pink) peptides are
shown as stick models. Helix a1C and sheet b5C–b7C are colored in green (NHERF-1 bound form) and red (ICAM-2 bound form).
(D) Rearrangements of the side chain packing of subdomain C. Sheet b5C–b7C is colored in green (NHERF-1 bound form) and red (ICAM-2 bound
form).
(E) The b-b interactions in subdomain C of the NHERF bound form. Hydrogen bonds are shown with broken lines.
(F) The b-b interactions in subdomain C of the ICAM-2 bound form.CFTR (Raghuram et al., 2001), while the dimerization ex-
hibits rather low affinity compared with that for ERM-
NHERF binding. NHERF-1 appeared to dimerize with
a Kd in the micromolar range (Shenolikar et al., 2001).
ERM proteins represent the most abundant cellular tar-
gets of NHERFs, and the active open form of ERM pro-
teins exists at or near the plasma membrane by anchor-
ing to the actin cytoskeleton (Murthy et al., 1998; Reczek
et al., 1997). Binding of NHERFs to the high-affinity bind-
ing target ERM proteins may determine the localization
of NHERFs at the plasma membrane and effectively in-
crease the local concentration of NHERFs, favoring
dimerization and accelerating binding to membrane
receptors and ion channels. This suggests that ERM
proteins are important components of cellular com-
plexes containing NHERF and play a role in regulatingNHERF function. NHERF-1 has lost its apical localization
in the intestine of ezrin-deficient mice (Saotome et al.,
2004).
NHERF mRNA was recently identified as being highly
induced by estrogen in estrogen-receptor (ER)-positive
breast cancer cells, and immunohistochemical studies
showed that NHERF expression was higher in breast tu-
mors compared with the expression found in adjacent
normal breast tissue (reviewed by [Voltz et al., 2001]).
Changes in Na+/H+ exchange play a role in tumor cell
pseudopodial extensions (Lagana et al., 2000). These
data suggest that NHERF may play a role in tumor de-
velopment. Physiological validation of our observed
Motif-2 binding and its interference with Motif-1 binding
should be tested by additional experiments such as
injection of Motif-1 or -2 peptides or expression of
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787Figure 7. Effects of NHERF Binding on Motif-1 Bindings of the FERM Domain
(A) Sensor diagrams obtained from SPR measurements with the ICAM-2 peptide immobilized to the sensor chip. Purified radixin FERM domain
(100 nM) was injected into the sensor chips with or without the NHERF-1 peptide used for the structural work. The concentrations of the NHERF-1
peptide are indicated.
(B) Sensor diagrams obtained from SPR measurements with the ICAM-2 peptide immobilized to the sensor chip. Purified radixin FERM domain
(100 nM) was injected into the sensor chips with or without the N-terminal-truncated NHERF-1 peptide (residues 344–358).
(C) Summary of SPR analyses of the binding of the FERM domain to several cytoplasmic tail peptides immobilized onto sensor chips. The ob-
served decreases (%) in resonances were plotted against NHERF-1 concentration. The peptides are for the juxtamembrane regions of mouse
adhesion molecules that have Motif-1, which binds the radixin FERM domain (Hamada et al., 2003): ICAM-2 (residues 250–277: HRRRTGTYGV
LAAWRRLPRAFRARPV); CD44 (residues 584–620: NSRRRCGQKKKLVINGGNGTVEDRKPSELNGEASKSQ); ICAM-1 (residues 483–510: QRKIRI
YKLQKAQEEAIKLKGQAPPP); and VCAM-1 (residues 720–739: ARKANMKGSYSLVEAQKSKV).mutated NHERF or ERM proteins in living cells. These
experiments would provide interesting insights and
might be of potential clinical significance and relevance.
The NHERF C-terminal tail consisting of ca. 120 resi-
dues follows two PDZ domains. This long tail seems to
be structurally flexible for the most part due to the pres-
ence of a serine-rich region spanning the N-terminal 90
residues of the tail. This region contains multiple phos-
phorylation sites, and it is known to affect NHERF dimer-
ization, thus facilitating activation of receptors including
CFTR and PDGFR (reviewed in [Shenolikar et al., 2004]).
The Ser-rich region containing the phosphorylation sites
is located more than 50 residues from the FERM binding
region at the C terminus. It seems unlikely that phos-
phorylation directly affects FERM binding; however, the
tail may fold back on itself, enabling the interaction be-
tween the phosphate group and the positively charged
region of the FERM binding region. Further work will
be needed to define the effect of phosphorylation on
FERM binding.
Experimental Procedures
Crystallization and Data Collection
The radixin FERM domain containing residues 1–310 was purified,
and crystals of the radixin FERM domain complexed with synthe-
sized NHERF peptides were obtained as described (Terawaki
et al., 2003). The crystal data and intensity statistics are summarized
in Table S1. Intensity data of the FERM-NHERF-1 complex, by using
flash-frozen crystals, were collected with an ADSC Quantum 4R
detector installed on the BL40B2 beamline at SPring-8 and were
processed with the programs MOSFLM (Leslie, 1992) and SCALA
(CCP4, 1994). Intensity data of the FERM-NHERF-2 complex, using
flash-frozen crystals, were collected with a MAR CCD detector
installed on the BL41XU beamline at SPring-8 in a similar manner
to that of the FERM-NHERF-1 complex. The data were processed
with DENZO/SCALEPACK (Otwinowski and Minor, 1997). These
crystals were nearly isomorphous to the crystals of the FERM-
NHERF-1 complex.
Structure Determination and Refinement
Initial phases were calculated by molecular replacement by using
a search model based on the free form structure of the radixin
FERM domain (Hamada et al., 2000) with the program AMoRe(Navaza, 1994). Following rigid-body refinement of the search model
performed with the program CNS (Bru¨nger et al., 1998), the phases
were improved by solvent flattening and histogram matching with
Solomon (Abrahams and Leslie, 1996). An initial model of the peptide
was built into the electron density map by using the graphics
program O (Jones et al., 1991) and was refined by the methods of
simulated annealing in CNS (Bru¨nger et al., 1998) and restraint
least-squares refinement in REFMAC (Murshudov et al., 1997). In
the peptide models, the side chains of residues 339–342, 350, and
353 were poorly defined in the current map and the structure with re-
placed alanines. The structure of the FERM-NHERF-2 complex was
solved by molecular replacement with the ERM-NHERF-1 structure
and was refined as shown in Table S1.
Structure Inspection
The stereochemical quality of the model was monitored by using the
program PROCHECK (Laskowski et al., 1993). There are two outliers
in the Ramachandran plot, Asp252 in the type II reverse turn be-
tween strands b5C and b6C and Lys262 in loop b6C–b7C. Ribbon
representations of the main chain folding of the molecule were
drawn with the program Molscript (Kraulis, 1991), while molecular
surface representations were drawn with the program GRASP (Nich-
olls et al., 1991). A schematic diagram of the interactions was pre-
pared with the program LIGPLOT (Wallace et al., 1995). There are
four crystallographic-independent protein-peptide complexes in
our crystal. All of the peptide binding sites faced toward the large
solvent channels in the crystal, and three complexes have no crystal
contact involving the peptide residues. The other complex has a few
crystal contacts involving the peptide residues (Asn357 and
Leu358), while no changes were found in the peptide conformation
compared with the peptides having no crystal contacts. Therefore,
we think that the crystal contacts do not affect the peptide confor-
mation and the binding mode to the FERM domain.
Peptide Binding Studies
The binding affinity for several mutated (replacement with alanine) or
truncated NHERF-1 peptides was examined by using equilibrium
SPR measurements rather than calorimetric or fluorimetric titration
methods because of the relatively low protein solubility and the
strong binding affinity. The SPR measurements were carried out
on a BIAcore Biosensor instrument (BIAcore 3000, Pharmacia Bio-
sensor) as previously described (Hamada et al., 2003). Biotinylated
polypeptides of the juxtamembrane regions of NHERF-1, NHERF-
2, and mutants were purchased from Sawady Technology (Tokyo,
Japan). The peptide was coupled via the N-terminal biotin moiety
to a streptavidin-coated sensor chip (sensor chip SA BIAcore AB).
The purified radixin FERM domain (0.1–1,000 nM) was injected into
both peptide-linked and nonlinked sensor chips for correction of
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788background signals. No net nonspecific binding of NHERF-1 pep-
tides was observed. All binding experiments were performed at
25ºC with a flow rate of 10 ml/min in buffer consisting of 10 mM
HEPES (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM DTT, and 0.05%
surfactant P20. The kinetic parameters were evaluated by using
the BIA evaluation software (Pharmacia). The Kd values were ob-
tained by averaging of at least three independent measurements
and are summarized in Table 1. Interference between Motif-1 and
Motif-2 binding to the FERM domain was tested by SPR analysis
of the binding of purified radixin FERM domain to the cytoplasmic
tail peptides of ICAM-2 (28 residues), ICAM-1 (28 residues),
VCAM-1 (20 residues), and CD44 (37 residues) immobilized on the
sensor chips. The purified radixin FERM domain (100 nM) was
injected into the sensor chips.
PIP2 Binding Studies
Effects of PIP2 on FERM binding to the NHERF or ICAM-2 peptide
were examined by SPR analysis of the binding of radixin FERM
domain to the peptides in a similar manner to that in interference be-
tween Motif-1 and Motif-2 binding to the FERM domain. The purified
radixin FERM domain (100 nM) was injected into the sensor chips
with or without soluble di-butanoyl-PIP2. We measured the binding
of the FERM domain to PIP2-containing lipid vesicles immobilized to
the L1 sensor chips by SPR measurements to estimate the Kd value.
The vesicles were prepared with PIP2-containig 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) by rehydration of dried
lipids in 5 mM Na2HPO4, 5 mM KH2PO4 (pH 7.4), and 150 mM NaCl.
All samples were injected into both the peptide-linked and nonlinked
sensor chips for correction of background signals.
Supplemental Data
Supplemental Data including figures for comparison of FERM bind-
ings between NHERF and the C-tail domain, induced-fit structural
changes in subdomain C, and tables for crystallographic analysis
and a list of NHERF-FERM interactions are available at http://
www.structure.org/cgi/content/full/14/4/777/DC1/.
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